NCT06549595 2026-04-17A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsAstraZenecaPhase 3 Recruiting1,018 enrolled
NCT06517511 2026-02-12Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)Sun Yat-sen UniversityPhase 2 Recruiting42 enrolled